Deals this week: MyoKardia, Kala Pharmaceuticals, Mesoblast

MyoKardia has announced plans to issue more than nine million shares of its common stock priced at $13.3 a share, to raise $122.15m in gross proceeds.

Source: Drug Development Technology - July 13, 2017 Category: Pharmaceuticals Source Type: news